Search Results - "Suetterlin, Martina"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Non‐clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist

    Non‐clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist by Murgasova, Renata, Carreras, Ester Tor, Suetterlin‐Hachmann, Martina, Silva Torrao, Leonel Reis, Kittelmann, Matthias, Alexandra, Vargas, Fredenhagen, Andreas

    Published in Biopharmaceutics & drug disposition (01-04-2020)
    “…EMA401, (the S‐enantiomer of 5‐(benzyloxy)‐2‐(2,2‐diphenylacetyl)‐6‐methoxy‐1,2,3,4‐tetrahydroisoquinoline‐3‐carboxylic acid), also known as Olodanrigan, is an…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats

    New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats by Walles, Markus, Rudolph, Bettina, Wolf, Thierry, Bourgailh, Julien, Suetterlin, Martina, Moenius, Thomas, Peraus, Gisela, Heudi, Olivier, Elbast, Walid, Lanshoeft, Christian, Bilic, Sanela

    Published in Drug metabolism and disposition (01-07-2016)
    “…For antibody drug conjugates (ADCs), the fate of the cytotoxic payload in vivo needs to be well understood to mitigate toxicity risks and properly design the…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: